BIOREGENX, INC. Increase (Decrease) in Accrued Liabilities
BIOREGENX, INC. (BRGX) reported Increase (Decrease) in Accrued Liabilities of $33.72 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-05-20
- BIOREGENX, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $33.72K, a 45.24% decline year-over-year.
- BIOREGENX, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $53.77K, a 47.68% increase year-over-year.
- BIOREGENX, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$24.90K, a 187.54% decline year-over-year.
- BIOREGENX, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-06-30 was -$109.04K, a 406.31% decline year-over-year.
- BIOREGENX, INC. increase (decrease) in accrued liabilities for fiscal 2025 was -$18.59K, a 131.15% decline from fiscal 2024.
- BIOREGENX, INC. increase (decrease) in accrued liabilities for fiscal 2024 was $59.68K, a 736.83% increase from fiscal 2023.
- BIOREGENX, INC. increase (decrease) in accrued liabilities for fiscal 2023 was $7.13K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $33.72K 10-Q · filed 2026-05-20 | $87.49K derived: sum of 2 quarters · filed 2026-05-20 | $62.59K derived: sum of 3 quarters · filed 2026-05-20 | -$46.44K derived: sum of 4 quarters · filed 2026-05-20 | |
| 2025-12-31 | $53.77K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $28.88K derived: sum of 2 quarters · filed 2026-04-15 | -$80.16K derived: sum of 3 quarters · filed 2026-04-15 | -$18.59K 10-K · filed 2026-04-15 | |
| 2025-09-30 | -$24.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$133.93K derived: sum of 2 quarters · filed 2025-11-14 | -$72.36K 10-Q · filed 2025-11-14 | -$35.95K derived: sum of 4 quarters · filed 2026-05-20 | |
| 2025-06-30 | -$109.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$47.47K 10-Q · filed 2025-08-14 | -$11.05K derived: sum of 3 quarters · filed 2026-05-20 | $17.39K derived: sum of 4 quarters · filed 2026-05-20 | |
| 2025-03-31 | $61.57K 10-Q · filed 2026-05-20 | $97.98K derived: sum of 2 quarters · filed 2026-05-20 | $126.42K derived: sum of 3 quarters · filed 2026-05-20 | $162.02K derived: sum of 4 quarters · filed 2026-05-20 | |
| 2024-12-31 | $36.41K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $64.85K derived: sum of 2 quarters · filed 2026-04-15 | $100.45K derived: sum of 3 quarters · filed 2026-04-15 | $59.68K 10-K · filed 2026-04-15 | $61.58K 10-K · filed 2025-04-15 |
| 2024-09-30 | $28.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $64.04K derived: sum of 2 quarters · filed 2025-11-14 | $23.27K 10-Q · filed 2025-11-14 | -$113.71K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $35.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$5.17K 10-Q · filed 2025-08-14 | -$142.15K derived: sum of 3 quarters · filed 2025-08-14 | ||
| 2024-03-31 | -$40.76K 10-Q · filed 2025-05-15 | -$177.75K derived: sum of 2 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -$136.98K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-04-16 | $7.13K 10-K/A · filed 2025-04-16 | |||
| 2023-09-30 | $144.12K 10-Q · filed 2024-11-14 |